439 related articles for article (PubMed ID: 32698510)
1. The Effect of JAK Inhibitor on the Survival, Anagen Re-Entry, and Hair Follicle Immune Privilege Restoration in Human Dermal Papilla Cells.
Kim JE; Lee YJ; Park HR; Lee DG; Jeong KH; Kang H
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32698510
[TBL] [Abstract][Full Text] [Related]
2. Effects of mesenchymal stem cell therapy on alopecia areata in cellular and hair follicle organ culture models.
Kim JE; Oh JH; Woo YJ; Jung JH; Jeong KH; Kang H
Exp Dermatol; 2020 Mar; 29(3):265-272. PubMed ID: 30372797
[TBL] [Abstract][Full Text] [Related]
3. Hair growth-promoting effects of Enz_MoriL on human dermal papilla cells through modulation of the Wnt/β-Catenin and JAK-STAT signaling pathways.
Chang B; Bae J; Lee DS; Kim S
Arch Dermatol Res; 2024 May; 316(6):290. PubMed ID: 38809465
[TBL] [Abstract][Full Text] [Related]
4. Mesenchymal Stem Cells Antagonize IFN-Induced Proinflammatory Changes and Growth Inhibition Effects via Wnt/β-Catenin and JAK/STAT Pathway in Human Outer Root Sheath Cells and Hair Follicles.
Lee YJ; Park SH; Park HR; Lee Y; Kang H; Kim JE
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33925529
[TBL] [Abstract][Full Text] [Related]
5. Mycophenolate antagonizes IFN-γ-induced catagen-like changes via β-catenin activation in human dermal papilla cells and hair follicles.
Ryu S; Lee Y; Hyun MY; Choi SY; Jeong KH; Park YM; Kang H; Park KY; Armstrong CA; Johnson A; Song PI; Kim BJ
Int J Mol Sci; 2014 Sep; 15(9):16800-15. PubMed ID: 25247578
[TBL] [Abstract][Full Text] [Related]
6. Selective inhibition of JAK3 signaling is sufficient to reverse alopecia areata.
Dai Z; Chen J; Chang Y; Christiano AM
JCI Insight; 2021 Apr; 6(7):. PubMed ID: 33830087
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-15 is a hair follicle immune privilege guardian.
Suzuki T; Chéret J; Scala FD; Rajabi-Estarabadi A; Akhundlu A; Demetrius DL; Gherardini J; Keren A; Harries M; Rodriguez-Feliz J; Epstein G; Lee W; Purba T; Gilhar A; Paus R
J Autoimmun; 2024 May; 145():103217. PubMed ID: 38581915
[TBL] [Abstract][Full Text] [Related]
8. An overview of JAK/STAT pathways and JAK inhibition in alopecia areata.
Lensing M; Jabbari A
Front Immunol; 2022; 13():955035. PubMed ID: 36110853
[TBL] [Abstract][Full Text] [Related]
9. An Open-Label Pilot Study to Evaluate the Efficacy of Tofacitinib in Moderate to Severe Patch-Type Alopecia Areata, Totalis, and Universalis.
Jabbari A; Sansaricq F; Cerise J; Chen JC; Bitterman A; Ulerio G; Borbon J; Clynes R; Christiano AM; Mackay-Wiggan J
J Invest Dermatol; 2018 Jul; 138(7):1539-1545. PubMed ID: 29452121
[TBL] [Abstract][Full Text] [Related]
10. 3-Deoxysappanchalcone Promotes Proliferation of Human Hair Follicle Dermal Papilla Cells and Hair Growth in C57BL/6 Mice by Modulating WNT/β-Catenin and STAT Signaling.
Kim YE; Choi HC; Lee IC; Yuk DY; Lee H; Choi BY
Biomol Ther (Seoul); 2016 Nov; 24(6):572-580. PubMed ID: 27795451
[TBL] [Abstract][Full Text] [Related]
11. Alopecia areata is driven by cytotoxic T lymphocytes and is reversed by JAK inhibition.
Xing L; Dai Z; Jabbari A; Cerise JE; Higgins CA; Gong W; de Jong A; Harel S; DeStefano GM; Rothman L; Singh P; Petukhova L; Mackay-Wiggan J; Christiano AM; Clynes R
Nat Med; 2014 Sep; 20(9):1043-9. PubMed ID: 25129481
[TBL] [Abstract][Full Text] [Related]
12. The Use of Janus Kinase Inhibitors in Alopecia Areata: A Review of the Literature.
Crowley EL; Fine SC; Katipunan KK; Gooderham MJ
J Cutan Med Surg; 2019; 23(3):289-297. PubMed ID: 30688081
[TBL] [Abstract][Full Text] [Related]
13. Hair follicle immune privilege and its collapse in alopecia areata.
Bertolini M; McElwee K; Gilhar A; Bulfone-Paus S; Paus R
Exp Dermatol; 2020 Aug; 29(8):703-725. PubMed ID: 32682334
[TBL] [Abstract][Full Text] [Related]
14. Phloroglucinol Enhances Anagen Signaling and Alleviates H
Park S; Lim YJ; Kim HS; Shin HJ; Kim JS; Lee JN; Lee JH; Bae S
J Microbiol Biotechnol; 2024 Apr; 34(4):812-827. PubMed ID: 38480001
[TBL] [Abstract][Full Text] [Related]
15. Restoration of Immune Privilege in Human Dermal Papillae Controlling Epithelial-Mesenchymal Interactions in Hair Formation.
Park JM; Jun MS; Kim JA; Mali NM; Hsi TC; Cho A; Kim JC; Kim JY; Seo I; Kim J; Kim M; Oh JW
Tissue Eng Regen Med; 2022 Feb; 19(1):105-116. PubMed ID: 34626334
[TBL] [Abstract][Full Text] [Related]
16. Oral ruxolitinib induces hair regrowth in patients with moderate-to-severe alopecia areata.
Mackay-Wiggan J; Jabbari A; Nguyen N; Cerise JE; Clark C; Ulerio G; Furniss M; Vaughan R; Christiano AM; Clynes R
JCI Insight; 2016 Sep; 1(15):e89790. PubMed ID: 27699253
[No Abstract] [Full Text] [Related]
17. Alopecia Areata: New Treatment Options Including Janus Kinase Inhibitors.
Zheng C; Tosti A
Dermatol Clin; 2021 Jul; 39(3):407-415. PubMed ID: 34053594
[TBL] [Abstract][Full Text] [Related]
18. Treatment of in vitro generated Langerhans cells with JAK-STAT inhibitor reduces their inflammatory potential.
Ann S; Ibo J; Megha M; Reu Hans D; Bruggen Laura V; Julien L; An B; Nathalie C
Clin Exp Med; 2023 Oct; 23(6):2571-2582. PubMed ID: 36282458
[TBL] [Abstract][Full Text] [Related]
19. Collapse and Restoration of Hair Follicle Immune Privilege Ex Vivo: A Model for Alopecia Areata.
Fehrholz M; Bertolini M
Methods Mol Biol; 2020; 2154():133-141. PubMed ID: 32314213
[TBL] [Abstract][Full Text] [Related]
20. Wnt/β-catenin and ERK pathway activation: A possible mechanism of photobiomodulation therapy with light-emitting diodes that regulate the proliferation of human outer root sheath cells.
Kim JE; Woo YJ; Sohn KM; Jeong KH; Kang H
Lasers Surg Med; 2017 Dec; 49(10):940-947. PubMed ID: 28944964
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
